Oncology PracticeAsymptomatic screening for COVID-19 in cancer patients still debatedFebruary 9, 2021Patient & Survivor CareBreast CancerCOVID-19 UpdatesGastrointestinal CancerGenitourinary CancerGynecologic CancerHead & Neck/Thyroid Cancers
Oncology PracticeManaging cancer outpatients during the pandemic: Tips from MSKCCFebruary 8, 2021Patient & Survivor CarePractice ManagementCOVID-19 UpdatesBreast CancerCNS/Brain CancerGastrointestinal CancerGenitourinary Cancer
Oncology PracticeLong-term metformin use linked to fewer ER+ breast cancersFebruary 8, 2021Breast Cancer
Early breast cancer: Real-world recurrence with IORT higher than previously reportedFebruary 5, 2021Breast Cancer
Heterogeneity in risk factors for symptom- vs. screen-detected breast cancerFebruary 5, 2021Breast Cancer
HER+ early breast cancer: Fixed-dose SC pertuzumab-trastuzumab noninferior to IV dosingFebruary 5, 2021Breast Cancer
Adjuvant S-1 plus endocrine therapy improves invasive DFS in ER+/HER2− breast cancerFebruary 5, 2021Breast Cancer
Does metabolic syndrome influence outcomes in triple-negative breast cancer?February 5, 2021Breast Cancer
Palbociclib+ET fails to prolong PFS in AI-resistant metastatic breast cancerFebruary 5, 2021Breast Cancer
One-third of HER2+ and triple-negative metastatic breast cancer patients develop brain metastasesFebruary 5, 2021Breast Cancer
Partial breast irradiation vs. whole breast irradiation for early breast cancerFebruary 5, 2021Breast Cancer
Oncology PracticeStudy flags cardiovascular disease in men with breast cancerFebruary 2, 2021Breast Cancer
